Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KK9V
|
|||
| Former ID |
DNCL003562
|
|||
| Drug Name |
GI-4000 + gemcitabine
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 2 | [1] | |
| Company |
GlobeImmune
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Mutated KRAS (mKRAS) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of GlobeImmune. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.